Business
Update to the Sale of Shares
Update to the Sale of Shares.
About this update from Valirx Plc
[{"type":"text","content":"\n RNS Number : 7531P ValiRx PLC 31 March 2009 \n \nValiRx plc\n\n(the 'Company')\n\nUpdate to the Sale of Shares Agreement\n\nThe Company announces that it has agreed amended payment terms with Biofield Corp ('Biofield') for the payment of Eur 600,000 as consideration due to the Company following the disposal of 10 per cent. of the Company's holding in its subsidiary, ValiBio S.A.. Under the amended payment terms, the Company will receive monthly payments commencing from 1 June, 2009. The Company will receive an additional Eur 60,000 to compensate the Company for the delay in payment of the initial consideration.\n\nFor further information contact:\n\n\n\n\n\nValiRx plc\n\n\nTel: +44 (0) 20 3008 4416\n\n\n\n\nDr. Satu Vainikka\n\n\n\n\n\n\n\n\nWH Ireland Limited - NOMAD & Broker\n\n\n\nTel: +44 (0) 161 832 2174\n\n\n\n\nDavid Youngman / Adrian Kirk\n\n\n\n\n\n\n\n\nCollege Hill \n\n\n\nTel: +44 (0) 20 7457 2020\n\n\n\n\nSue Charles / Adrian Duffield / Justine Lamond\n\n\[email protected] \n\n\n\n\n\nThis information is provided by RNSThe company news service from the London Stock Exchange END AGRWUUGWWUPBGQU \n ","length":2997,"tagName":"div"}]